- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02585193
Evaluation of a Commercial Program on Weight Loss and Health Outcomes
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
There is a body of evidence that has evaluated the effect of Weight Watchers, a commercially available weight loss program, on changes in body weight. The current investigation aims to add to this body of evidence by providing additional data on changes in body weight and enhance the current evidence-base in regards to evaluating other health-related outcomes.
There is no evidence that demonstrates whether or not the weight loss as a result of the Weight Watchers program elicits changes in health-related outcomes related to aerobic capacity, flexibility, functional fitness, sleep, and other psychological measures. Additionally, within a scientific research protocol, measures of adherence and satisfaction have not been evaluated. This study will evaluate these outcomes beyond weight changes achieved across the 24-week program.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, Forenede Stater, 15261
- Physical Activity and Weight Management Research Center / University of Pittsburgh
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Male or female over age 18. Set "soft quotas" on the number of male and female participants - The desire is to have a 90% female / 10% male split.
- With or without previous Weight Watchers experience. Set quota on the number of participants with previous Weight Watchers experience at 65%.
- Self reported height/weight resulting in a Body Mass Index (BMI) of 27 to 43 kg/m2 (will re-screen at facility).
- Self report that he/she feels the need to lose weight.
- Willing to discontinue any current over-the-counter (OTC) supplements not recommended/prescribed by physician, with the exception of multivitamins or other vitamin supplement.
- Willing to follow recommendations required by study protocol.
- Willing to include demographic information (e.g., ethnicity, income and education).
- Willing to participate in consumer surveys and focus groups as a part of the intervention.
- Use of a personal smartphone on a daily basis. For Android devices, must be version 4.4 (code: KitKat) or 5.0 (codename: Lollipop). For iPhones, must be iOS6 and above. Cannot accommodate Blackberry devices.
- The willingness and ability to navigate and use applications on their smartphone on a daily basis (minimum training will be provided).
- Reliable home WiFi access
Ability to commit to attending up to 27 study visits in approximately 26 weeks:
- Ability to commit (to best of their ability) to attending weekly meetings, 30-60 minutes in duration, at the same day and time each week for 24 consecutive weeks (daytime and evening options will be available).
- Ability to commit to up to 3 additional study visits at Weeks 0, 12, and 24, each approximately 90 minutes in duration, to complete assessments (height, weight, questionnaires, physical measures).
Exclusion Criteria:
- Participants that are currently following a commercial weight-loss program.
- Participants that have been involved in a related market research program within the last 6 months.
- Pregnant or nursing, or planning on becoming pregnant over the next 9 months.
- Recent weight loss of ≥ 5 kg in the previous 3 months.
- History of clinically diagnosed eating disorder.
- Orthopedic limitations preventing participation in regular physical activity.
- Untreated thyroid disease or > 1 change in dose or type of thyroid medication over previous 6 months.
Taking any prescription medication with known effects on appetite or weight.
*With the exception of subjects on a stable dose of SSRIs (Selective Serotonin Re-uptake Inhibitors) for 6 months.
- Taking oral steroids.
- Chronic/inflammatory gastrointestinal disorders (irritable bowel syndrome acceptable).
- Previous surgical procedure for weight loss.
- Major surgery within the previous 3 months.
- History of heart problems (e.g., angina, bypass surgery, MI, etc) within previous 3 months.
- Presence of implanted cardiac defibrillator or pacemaker.
- Uncontrolled hypertension self-reported BP > 160/100mmHg)
- Diuretic use for hypertension over 1.5mg per day
- Diagnosis of type 1 or type 2 diabetes
- History of presence of cancer (completely respected basal or squamous cell carcinoma acceptable if treatment completed more than 6 months prior to enrollment).
- Consuming more than 14 alcoholic drinks per week or not more than 3 drinks per day.
- Planning to relocate in the next 9 months
- Any orthopedic limitation preventing participation in regular physical activity.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Andet: Weight Watchers Intervention
All participants are enrolled in this single arm of the study.
All participants receive the Weight Watchers intervention which consists of weekly group intervention/support meetings in which weight loss behaviors (diet, physical activity) are discussed.
|
All participants are enrolled in this single arm of the study.
All participants receive the Weight Watchers intervention which consists of weekly group intervention/support meetings in which weight loss behaviors (diet, physical activity) are discussed.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Body Weight Change
Tidsramme: 6 months
|
To examine the effect of a 24-week commercially available weight loss program on weight change.
|
6 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Sleep Quality and Duration
Tidsramme: 6 months
|
Sleep quality and duration.
Participants will be asked to complete the Pittsburgh Sleep Quality Index (PSQI) at baseline, Months 3 and 6.
The PSQI is a validated self-report measure of sleep duration and sleep quality.
|
6 months
|
|
Change in Happiness
Tidsramme: 6 months
|
Participants will be asked to complete the Oxford Happiness Questionnaire at baseline, Months 3 and 6.
The OHQ is a validated self-report measure for broad personal happiness.
Respondents rate 29 sentences on a 6 point Likert scale (1, strongly disagree; 6, strong agree).
|
6 months
|
|
Change in Food Cravings
Tidsramme: 6 months
|
The Food Craving Inventory-II (FCI-II) is a validated self-report measure for general cravings and cravings for specific types of foods and will be completed at baseline, Months 3 and 6.
Respondents rate the frequency of cravings since the last time they completed the survey for each of 33 food items using a five-point Likert scale (1, never; 2, rarely; 3, sometimes; 4, often; 5, always/almost every day).
The FCI-II consists of 5 scales (sweets, high fats, carbohydrates/starches, fast food fats, and fruits & vegetables) that constitute the higher order construct of food cravings (the total score).
|
6 months
|
|
Program Satisfaction
Tidsramme: 6 months
|
Program Satisfaction. Two parts to evaluate:
|
6 months
|
|
Program Adherence
Tidsramme: 6 months
|
Data on adherence (attendance at meetings and use of the points system) will also be collected.
Attendance data will be recorded by Weight Watchers staff at every meeting.
These data will be confirmed by a member of the research staff that will be attending the weekly Weight Watchers meetings.
In addition, the weekly weights obtained at the intervention sessions will be provided to the investigators by the intervention staff to allow for examination of the trajectory of weight loss.
|
6 months
|
|
Change in Aerobic Capacity, Functional Fitness, Balance, Flexibility
Tidsramme: 6 months
|
Aerobic Capacity: Participants will complete a 6 minute walk test on a designated walking course. The 6 minute walk test is a measure of functional and aerobic capacity. Participants will asked to walk at a brisk, yet comfortable pace for a total of 6 minutes. Functional Fitness and Balance: The Short Physical Performance Battery (SPPB) is a group of measures that combines the results of the gait speed, chair stand and balance tests to measure functional fitness. Flexibility: Lower body flexibility will be assessed through the sit and reach test. The sit and reach is a common test to measure lower back and lower body flexibility. This will be collected 3 times with the best of 3 scores utilized. |
6 months
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Renee J Rogers, PhD, University of Pittsburgh
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- PRO15040047
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Weight Watchers Intervention
-
KK Women's and Children's HospitalAfsluttetVægtændringSingapore
-
University of California, San FranciscoTrukket tilbageSygelig fedmeForenede Stater
-
University of VermontAfsluttet
-
University of RochesterAfsluttetFedme | OvervægtigForenede Stater
-
SymmetryScience Group, Inc.AfsluttetSund og rask | Eksem | Atopisk dermatitisForenede Stater
-
University Hospital, Clermont-FerrandUniversity Hospital, Toulouse; Hôpital Haut-LévêqueIkke rekrutterer endnu
-
Case Comprehensive Cancer CenterSuspenderetGlioblastom | Anfald | Venøs tromboembolismeForenede Stater
-
Stanford UniversityTilmelding efter invitation
-
Tufts UniversityAfsluttet
-
University of ConnecticutNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) og andre samarbejdspartnereRekruttering